Metric
Kymriah
Yescarta
Health Canada Notice of Compliance (NOC)
September 2018
February 2019
Indication(s)
  • Pediatric Acute Lymphoblastic Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Relapsed or Refractory Large B-cell Lymphoma
Health Technology Expert Review Panel (HTERP) evaluation completed
January 15, 2019
August 15, 2019
Funding Status
Quebec: October 2019
Ontario: December 2019
Alberta: August 2020